Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amedisys, Inc. stock logo
AMED
Amedisys
$94.50
+0.2%
$92.21
$82.15
$98.95
$3.10B0.89404,999 shs361,426 shs
Chemed Co. stock logo
CHE
Chemed
$556.57
+1.8%
$587.66
$512.12
$623.61
$8.13B0.4998,335 shs118,857 shs
CorVel Co. stock logo
CRVL
CorVel
$110.31
-0.8%
$110.59
$76.53
$128.61
$5.67B0.94117,090 shs185,999 shs
DaVita Inc. stock logo
DVA
DaVita
$139.57
+0.0%
$146.50
$131.27
$179.60
$11.17B1.04838,356 shs600,714 shs

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amedisys, Inc. stock logo
AMED
Amedisys
0.00%+2.99%+1.94%+2.04%+2.95%
Chemed Co. stock logo
CHE
Chemed
0.00%-4.13%-8.15%-3.08%-0.69%
CorVel Co. stock logo
CRVL
CorVel
0.00%-4.15%-0.94%-5.21%+38.67%
DaVita Inc. stock logo
DVA
DaVita
0.00%-0.46%-7.13%-20.49%+4.54%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amedisys, Inc. stock logo
AMED
Amedisys
2.739 of 5 stars
1.12.00.05.02.21.71.3
Chemed Co. stock logo
CHE
Chemed
4.4681 of 5 stars
2.53.03.34.92.12.51.3
CorVel Co. stock logo
CRVL
CorVel
0.9309 of 5 stars
0.02.00.00.03.13.30.0
DaVita Inc. stock logo
DVA
DaVita
4.2702 of 5 stars
2.03.00.04.53.01.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amedisys, Inc. stock logo
AMED
Amedisys
2.20
Hold$100.756.61% Upside
Chemed Co. stock logo
CHE
Chemed
3.00
Buy$667.0019.84% Upside
CorVel Co. stock logo
CRVL
CorVel
0.00
N/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
2.00
Hold$166.3319.18% Upside

Current Analyst Ratings Breakdown

Latest AMED, DVA, CHE, and CRVL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/16/2025
Amedisys, Inc. stock logo
AMED
Amedisys
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.00
3/14/2025
Chemed Co. stock logo
CHE
Chemed
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$633.00 ➝ $667.00
3/4/2025
Amedisys, Inc. stock logo
AMED
Amedisys
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$101.00 ➝ $101.00
2/21/2025
DaVita Inc. stock logo
DVA
DaVita
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$184.00
2/18/2025
DaVita Inc. stock logo
DVA
DaVita
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
2/18/2025
DaVita Inc. stock logo
DVA
DaVita
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$164.00 ➝ $169.00
2/12/2025
Amedisys, Inc. stock logo
AMED
Amedisys
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$101.00 ➝ $101.00
(Data available from 4/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amedisys, Inc. stock logo
AMED
Amedisys
$2.37B1.31$6.39 per share14.80$34.31 per share2.75
Chemed Co. stock logo
CHE
Chemed
$2.49B3.27$24.85 per share22.40$73.55 per share7.57
CorVel Co. stock logo
CRVL
CorVel
$871.31M6.50$1.93 per share57.19$5.86 per share18.82
DaVita Inc. stock logo
DVA
DaVita
$12.82B0.87$18.29 per share7.63$4.95 per share28.20
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amedisys, Inc. stock logo
AMED
Amedisys
-$9.75M$2.7137.5019.521.783.57%12.20%6.74%N/A
Chemed Co. stock logo
CHE
Chemed
$272.51M$20.5328.1223.892.1512.69%27.86%19.12%N/A
CorVel Co. stock logo
CRVL
CorVel
$76.25M$1.7064.89N/A10.12%32.22%17.66%5/19/2025 (Estimated)
DaVita Inc. stock logo
DVA
DaVita
$936.34M$10.7413.0010.981.077.31%115.48%4.94%5/1/2025 (Estimated)

Latest AMED, DVA, CHE, and CRVL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
DaVita Inc. stock logo
DVA
DaVita
$1.75N/AN/AN/A$3.22 billionN/A
4/23/2025Q1 2025
Amedisys, Inc. stock logo
AMED
Amedisys
$1.13$1.25+$0.12$1.84$597.43 million$594.78 million
2/26/2025Q4 2024
Amedisys, Inc. stock logo
AMED
Amedisys
$1.05$0.96-$0.09-$0.62$602.38 million$598.05 million
2/13/2025Q4 2024
DaVita Inc. stock logo
DVA
DaVita
$2.14$2.24+$0.10$3.09$3.27 billionN/A
2/4/2025Q3 2025
CorVel Co. stock logo
CRVL
CorVel
N/A$0.46N/A$0.46N/AN/A
2/4/2025Q3 2025
CorVel Co. stock logo
CRVL
CorVel
N/A$0.46N/A$0.46N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amedisys, Inc. stock logo
AMED
Amedisys
N/AN/AN/AN/AN/A
Chemed Co. stock logo
CHE
Chemed
$2.000.36%+8.74%9.74%16 Years
CorVel Co. stock logo
CRVL
CorVel
N/AN/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A

Latest AMED, DVA, CHE, and CRVL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/14/2025
Chemed Co. stock logo
CHE
Chemed
quarterly$0.500.36%2/24/20252/24/20253/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amedisys, Inc. stock logo
AMED
Amedisys
0.05
1.19
1.19
Chemed Co. stock logo
CHE
Chemed
N/A
1.85
1.81
CorVel Co. stock logo
CRVL
CorVel
N/A
1.77
1.77
DaVita Inc. stock logo
DVA
DaVita
23.18
1.26
1.21

Institutional Ownership

CompanyInstitutional Ownership
Amedisys, Inc. stock logo
AMED
Amedisys
94.36%
Chemed Co. stock logo
CHE
Chemed
95.85%
CorVel Co. stock logo
CRVL
CorVel
51.36%
DaVita Inc. stock logo
DVA
DaVita
90.12%

Insider Ownership

CompanyInsider Ownership
Amedisys, Inc. stock logo
AMED
Amedisys
2.10%
Chemed Co. stock logo
CHE
Chemed
3.29%
CorVel Co. stock logo
CRVL
CorVel
47.57%
DaVita Inc. stock logo
DVA
DaVita
2.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amedisys, Inc. stock logo
AMED
Amedisys
20,00032.81 million32.07 millionOptionable
Chemed Co. stock logo
CHE
Chemed
14,20014.62 million14.55 millionOptionable
CorVel Co. stock logo
CRVL
CorVel
4,23051.36 million26.93 millionOptionable
DaVita Inc. stock logo
DVA
DaVita
70,00080.00 million78.40 millionOptionable

Recent News About These Companies

DaVita (NYSE:DVA) Upgraded at StockNews.com
DaVita Inc. stock logo
Natixis Takes Position in DaVita Inc. (NYSE:DVA)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amedisys stock logo

Amedisys NASDAQ:AMED

$94.50 +0.23 (+0.24%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$94.46 -0.04 (-0.04%)
As of 04/25/2025 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Chemed stock logo

Chemed NYSE:CHE

$556.57 +9.79 (+1.79%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$556.10 -0.46 (-0.08%)
As of 04/25/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

CorVel stock logo

CorVel NASDAQ:CRVL

$110.31 -0.86 (-0.77%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$108.81 -1.50 (-1.36%)
As of 04/25/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.

DaVita stock logo

DaVita NYSE:DVA

$139.57 +0.01 (+0.01%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$139.34 -0.23 (-0.17%)
As of 04/25/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.